Nerviano Medical Sciences
Clinical trials sponsored by Nerviano Medical Sciences, explained in plain language.
-
Experimental drug combo offers hope for Tough-to-Treat lung cancer
Disease control Recruiting nowThis early-stage study is testing a new drug called NMS-03305293 combined with an existing chemotherapy drug (temozolomide) for people with small cell lung cancer that has returned after previous treatments. The main goal is to check if this combination is safe and tolerable for …
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
Early trial tests promising new treatment for Tough-to-Treat ovarian cancer
Disease control Recruiting nowThis early-stage study is testing a new drug called NMS-03305293 combined with an existing chemotherapy (topotecan) for women with recurrent ovarian cancer. The main goals are to find the safest dose and see how well patients tolerate the combination. Researchers will also check …
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New hope for leukemia patients out of options
Disease control Recruiting nowThis early-stage study is testing a new oral drug called NMS-03597812 for adults with acute myeloid leukemia (AML) that has come back or not responded to standard treatments. The main goals are to find a safe dose and see if the drug can help put the cancer into remission. The st…
Phase: PHASE1 • Sponsor: Nerviano Medical Sciences • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC